Hematology status update: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
! Status | ! Status | ||
|- | |- | ||
| Hematology | | Hematology ||[[Anemia]] || [[Anemia resident survival guide]] || Chetan ||Complete | ||
|- | |- | ||
|Hematology | |Hematology | ||
|[[Polycythemia]] | |[[Polycythemia]] | ||
|[[Polycythemia resident survival guide]] | |[[Polycythemia resident survival guide]] | ||
Line 19: | Line 19: | ||
| | | | ||
|- | |- | ||
| Hematology | | Hematology ||[[Aplastic anemia]] || [[Aplastic anemia resident survival guide]] || Chetan ||Complete | ||
|- | |- | ||
| Hematology | | Hematology ||[[Hemolytic anemia]] || [[Hemolytic anemia resident survival guide]] |||| | ||
|- | |- | ||
| Hematology | | Hematology ||[[Heparin induced thrombocytopenia]] || [[HIT resident survival guide]] || Karol|| Complete | ||
|- | |- | ||
|Hematology | |Hematology | ||
|[[Immune Thrombocytopenia resident survival guide|Immune Thrombocytopenia]] | |[[Immune Thrombocytopenia resident survival guide|Immune Thrombocytopenia]] | ||
|[[Immune Thrombocytopenia resident survival guide]] | |[[Immune Thrombocytopenia resident survival guide]] | ||
Line 31: | Line 31: | ||
| - | | - | ||
|- | |- | ||
|Hematology | |Hematology | ||
|VTE | |VTE | ||
|[[VTE prevention resident survival guide]] | |[[VTE prevention resident survival guide]] | ||
Line 37: | Line 37: | ||
| | | | ||
|- | |- | ||
|Hematology | |Hematology | ||
|Acute Leukemia | |Acute Leukemia | ||
|[[Acute leukemia resident survival guide]] | |[[Acute leukemia resident survival guide]] | ||
Line 43: | Line 43: | ||
| | | | ||
|- | |- | ||
|Hematology | | Hematology ||[[Pancytopenia]]||[[Pancytopenia resident survival guide]]|| || | ||
|- | |- | ||
| Hematology | | Hematology ||[[Thrombocytopenia]]||[[Thrombocytopenia resident survival guide]]||Ogheneochuko|| Complete | ||
|- | |- | ||
| Hematology | | Hematology ||[[Febrile neutropenia]]||[[Febrile neutropenia resident survival guide]]|| Rim ||Complete | ||
|- | |- | ||
| Hematology | | Hematology ||[[Bleeding disorders]]||[[Bleeding disorder resident survival guide]]|| || | ||
|- | |- | ||
| Hematology | | Hematology ||[[DIC]]||[[DIC resident survival guide]]||Ogheneochuko|| Complete | ||
|- | |- | ||
|Hematology | | Hematology ||[[Transfusion therapy]]||[[Transfusion therapy resident survival guide]]||Ayokunle||Complete | ||
| | |||
|[[ | |||
| | |||
| | |||
|} | |} | ||
Revision as of 13:59, 23 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.
Organ System Project |
---|
Topics |
Leaders & Members |
Meetings' Summary |
System Leader: Ramyar Ghandriz, M.D.
Primary Care
Status Update
Progress | |
---|---|
Completed | 1 |
In progress | 4 |
Remaining | 16 |
List of Chapters Requiring Content
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Hematology |
|
||||||
|
|||||||
|
|||||||
|
|||||||
In progress chapters
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Hematology | Hemophilia | Assigned | Muhammad Adnan Heider | Abdelrahman | In progress | ||
Assigned | Ayushi Jane | Ramyar | In progress | ||||
Assigned | Asra Firdous | Ramyar | In progress | ||||
Assigned | Anum Dilip | Homa | In progress | ||||
Completed chapters
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Hematology | Needs Review | Ramyar | |||||
Needs Review | |||||||
Needs Review | |||||||
|
Needs Review | ||||||